Nineteen of 39 multiresistant strains of Serratia marcescens isolated from clinical sources transferred antibiotic resistance toEscherichia coli orKlebsiella pneumoniae recipients. Marcesins and/or phage prevented effective resistance transfer to E. coli and attempts to select marcescin-resistant mutants of the E. coli recipient strain were unsuccessful. Transfer of resistance was demonstrated for all drugs tested except nalidixic acid. Approximately 90% of donors resistant to tobramycin, ampicillin, or carbenicillin transferred resistance to these drugs.
The incidence of hospital-associated infections caused by Serratia marcescens has increased significantly in recent years (3, 4, 13) . Investigations of drug resistance in this species have shown Serratia to have resistance to a broader range of therapeutic agents than other Enterobacteriaceae (5, 7, 9, 13) . The contribu-. tion of R factors to the multiple resistance of Serratia was studied in 1969 by Medeiros and O'Brien (8) who found that 21 of 22 multipleresistant isolates transferred at least part of their resistance. They also concluded that multiple drug resistance is more prevalent in Serratia than in any other comxnonly isolated member of the Enterobacteriaceae, and that R factors not only mediated resistance to drugs to which the strain was previously susceptible but also conferred additional degrees of resistance to drugs to which the organism was already resistant.
Recently, 236 strains of Serratia marcescens obtained from Europe, Canada, and the United States were tested for R factor compatibility groups and transferability to Escherichia coli (7) . Only 27 strains transferred resistance; the R factors found belonged either to compatibility groups notable for their wide generic host range or to groups found only in Serratia.
In this study 39 multiresistant strains of S. marcescens isolated from clinical sources were studied to evaluate the prevalence, antibiotic resistance patterns, transmissibility, and stability of R factors in S. marcescens and in E. coli and Klebsiella pneumoniae transcipients.
MATERIALS AND METHODS Donors. From a collection of 102 strains of S. marcescens isolated from clinical sources at three medical centers (1), 39 multiresistant strains were selected for study. These strains were either resistant to antibiotics to which most strains in the collection were susceptible (streptomycin and kanamycin minimal inhibitory concentrations [MICs] :2 80 ,tg/ ml; chloramphenicol MIC 2 30 ,lg/ml; gentamicin and tobramycin MICs 2 16 ,ug/ml) or were resistant to unusually high levels of ampicillin or tetracycline (MIC 500 Sg/ml).
Recipients. Antibiotic-susceptible laboratory strains of E. coli K-12 and clinical strains of K. pneumoniawere selected as mating recipients. Thẽ ipl~firGrganisms and their selection markers are listed in Table 1. Conijugation. R factor transfer experiments were performed by the method described by Datta and Hedges (2) . Approximately 107 donor cells and 108 recipient cells were mixed and incubated at 37 C in a total volume of 2 ml of Penassay broth (Difco Laboratories, Detroit, Mich.), usually for 24 to 72 h with 1 ml of fresh broth added every 24 h. (Preliminary experiments had indicated that in some instances the frequency of resistance transfer was so low that a long period of mixed cultivation was necessary.) Mating mixtures were plated on antibiotic-containing or nutritionally selective media. Resistant progeny were tested by agar dilution methods for transferred patterns and levels of resistance.
Experiments to determine frequency of resistance transfer were performed as described above except that mating pairs were disrupted after 1 h by vigorous agitation. Transfer frequency was expressed as the number of resistant transcipients per donor cell.
Bacteriocin production. When results of mating 
RESULTS
Each of the 39 strains was incubated in mixed cultivation with E. coli CSH-27 (NalR). Only three strains (S3, S4, and S46) transferred resistance to this recipient. Death of the recipient due to production of marcescin and/or lytic phage by the Serratia donor was suspected as a cause for the failure of transfer in the majority of these matings (see later section).
Thirty-seven of the 39 multiresistant Serratia were incubated with K. pneumoniae strains KB5 or the derivative KB5-B1. Transfer of resistance was observed with 17 strains (Table 2) . No decline in viability of recipients was observed in any of these experiments, indicating the resistance of K. pneumoniae to marcescins and/or phage. Two donors (MDA20 and MDA761) transferred complete as well as partial resistance patterns to KB5-B1. The resistance pattern of Serratia N-12 segregated into two distinct patterns upon transfer, suggesting the possible existence of two R factors in this strain.
The proportion ofSerratia strains that transferred antibiotic resistance to K. pneumoniae or E. coli is shown in Table 3 . At least 88% of strains resistant to tobramycin, ampicillin, or carbenicillin transferred resistance to these drugs. The lowest frequency of transfer was for chloramphenicol; only 29% of donors transferred resistance.
Levels of resistance in E. coli and K. pneumoniae transcipients for nine antibiotics were compared with those of the Serratia donors. The highest levels of resistance in E. coli CSH-27 transcipients were to ampicillin, carbenicillin, and kanamycin. With the exception of these drugs and tetracycline, resistance levels in E. coli CSH-27 transcipients were lower than in the Serratia donors. When resistance levels in Klebsiella transcipients were compared with those of the Serratia donors, it was found that low (MIC = 10 to 80 ,g/ml) and high (MIC = 2,500 to 5,000 ,ug/ml) levels of resistance to ampicillin were found in both organisms. Levels of resistance to the other drugs were generally less in K. pneumoniae than in S. marcescens. However, high-level kanamycin resistance (MIC > 5,000 ,ug/ml) was observed in K. pneumoniae transcipients of R factors from three of four Serratia with high-level kanamycin resistance. High levels of resistance to the ,8-lactam drugs and kanamycin were maintained in two of three E. coli W1485 transcipients receiving Serratia R factors from K. pneumohiae. In one case (N-12) the levels of resistance to chloramphenicol and to tetracycline were greater inE. coli K-12 than in theK. pneumoniae donor.
Frequency of transfer of Serratia R factors from various donor.organisms to E. coli W1485 was determined by 1-h matings. The results of 1-h matings between five E. coli and one K. pneumoniae donors and E. coli W1485 recipients are shown in creased survival when mixed with marcescinproducing Serratia strains. The stability of resistance markers in Serratia donors and in their transcipients was also studied. None of the four Serratia tested exhibited any loss of resistance after 24-h broth passage, indicating relative R factor stability in the original host strain (Table 5 ). In the transcipients there were notable losses of resistance, especially to cephalothin, carbenicillin, ampicillin, and tetracycline. DISCUSSION In this study 19 of39 multiresistant strains of S. marcescens transferred resistance to recipient strains of K. pneumoniae or E. coli. K. pneumoniae proved to be a better recipient than E. coli for Serratia R factors; only 3 of 39 strains transferred resistance to E. coli. Nineteen of 28 S. marcescens strains examined were found to produce bacteriocins lethal for the intended E. coli K-12 recipient (6). 10, 1976 quencies of transfer were found in experiments in which the E. coli donors and recipients were isogenic.
With a few exceptions, levels of resistance to most drugs were higher in Serratia organisms than in K. pneumoniae or E. coli. This may indicate a higher degree of intrinsic resistance in S. marcescens or may possibly be related to the presence of multiple copies of R factors in the Serratia host.
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